Enzaplatovir

Names

[ Name ]:
Enzaplatovir

[Synonym ]:
OZ40XB915E
UNII:OZ40XB915E
enzaplatovir
1H,5H-Imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one, 2,3,10,10a-tetrahydro-1-[(3-methyl-4-isoxazolyl)carbonyl]-10a-(6-methyl-3-pyridinyl)-, (10aR)-
(10aR)-1-[(3-Methyl-1,2-oxazol-4-yl)carbonyl]-10a-(6-methyl-3-pyridinyl)-2,3,10,10a-tetrahydro-1H,5H-imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one

Biological Activity

[Description]:

Enzaplatovir (BTA-585, BTA-C585) is an orally bioavailable RSV fusion protein inhibitor for the treatment of respiratory syncytial virus infections. RSV Infection Phase 2 Discontinued

[References]

References View Related Products by Target RSV RSV Infection

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
663.0±55.0 °C at 760 mmHg

[ Molecular Formula ]:
C₂₀H₁₉N₅O₃

[ Molecular Weight ]:
377.397

[ Flash Point ]:
354.8±31.5 °C

[ Exact Mass ]:
377.148804

[ LogP ]:
-0.43

[ Vapour Pressure ]:
0.0±2.0 mmHg at 25°C

[ Index of Refraction ]:
1.731

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.